2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole

C16H19F3N6O — CID 126893457

IUPAC2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole
SMILESFC(F)(F)c1nnc(CN2CC(N3CCN(c4ccccn4)CC3)C2)o1
InChIInChI=1S/C16H19F3N6O/c17-16(18,19)15-22-21-14(26-15)11-23-9-12(10-23)24-5-7-25(8-6-24)13-3-1-2-4-20-13/h1-4,12H,5-11H2
InChIKeyVRMQMHBCGRRFCT-UHFFFAOYSA-N
MW368.36 g/mol
LogP1.49
Rot. Bonds4

About 2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole

2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole (PubChem CID 126893457) has the molecular formula C16H19F3N6O and a molecular weight of 368.36 g/mol. Its IUPAC name is 2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole.

Molecular Properties

Compound Name2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole
PubChem CID126893457
Molecular FormulaC16H19F3N6O
Molecular Weight368.36 g/mol
Exact Mass368.16
IUPAC Name2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole
SMILESFC(F)(F)c1nnc(CN2CC(N3CCN(c4ccccn4)CC3)C2)o1
InChIInChI=1S/C16H19F3N6O/c17-16(18,19)15-22-21-14(26-15)11-23-9-12(10-23)24-5-7-25(8-6-24)13-3-1-2-4-20-13/h1-4,12H,5-11H2
InChIKeyVRMQMHBCGRRFCT-UHFFFAOYSA-N
XLogP1.49
TPSA61.53 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500368.36
LogP ≤ 51.49
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole?
The IUPAC name of 2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole (CID 126893457) is 2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole.
What is the SMILES notation for 2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole?
The canonical SMILES for 2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole is FC(F)(F)c1nnc(CN2CC(N3CCN(c4ccccn4)CC3)C2)o1.
What is the InChIKey of 2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole?
The InChIKey is VRMQMHBCGRRFCT-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H19F3N6O/c17-16(18,19)15-22-21-14(26-15)11-23-9-12(10-23)24-5-7-25(8-6-24)13-3-1-2-4-20-13/h1-4,12H,5-11H2.
What are the key properties of 2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole?
2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole has a molecular weight of 368.36 g/mol, XLogP of 1.49, 4 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[3-(4-pyridin-2-ylpiperazin-1-yl)azetidin-1-yl]methyl]-5-(trifluoromethyl)-1,3,4-oxadiazole is sourced from PubChem (CID 126893457), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).